Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy

Lignende værker

• Very Late Stent Thrombosis after Drug-Eluting Stent Implantation in a Patient without Aspirin and Clopidogrel Resistance
  af: Lim, Sang Yup, et al.
  Udgivet: (2008)
• Clopidogrel versus Aspirin after Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stenting
  af: Sim, Doo Sun, et al.
  Udgivet: (2019)
• Comparison of Triple Anti-Platelet Therapy (Aspirin, Clopidogrel, and Cilostazol) and Double Anti-Platelet Therapy (Aspirin and Clopidogrel) on Platelet Aggregation in Type 2 Diabetic Patients Undergoing Drug-Eluting Stent Implantation
  af: Yang, Tae-Hyun, et al.
  Udgivet: (2009)
• Stent thrombosis associated with first-generation drug-eluting stents: issues with antiplatelet therapy
  af: Gurbel, P.A., et al.
  Udgivet: (2007)
• Twelve Months Dual Antiplatelet Therapy after Drug-eluting Stents – Too Long, too Short or Just Right?
  af: Sahebjalal, Mohammad, et al.
  Udgivet: (2015)